iHCK-37

Catalog No. :
ACEHQQ743
CAS No. :
516478-09-4
Molecular Formula :
C30H32N4O2S2
Molecular Weight :
544.75

IUPAC Name:N-(2-morpholinophenyl)-2-((2-phenethyl-5,6,7,8-tetrahydrobenzo[4,5]thieno[2,3-d]pyrimidin-4-yl)thio)acetamide

iHCK-37 structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1mg98%$206.00Login to see priceInquiryInquiry
5mg98%$454.00Login to see priceInquiryInquiry
10mg98%$715.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameiHCK-37
IUPAC NameN-(2-morpholinophenyl)-2-((2-phenethyl-5,6,7,8-tetrahydrobenzo[4,5]thieno[2,3-d]pyrimidin-4-yl)thio)acetamide
Molecular FormulaC30H32N4O2S2
Molecular Weight544.75
SMILESO=C(NC1=CC=CC=C1N2CCOCC2)CSC3=C(C4=C(CCCC4)S5)C5=NC(CCC6=CC=CC=C6)=N3
InChI KeyYBVMBFMOYYGDEM-UHFFFAOYSA-N
SynonymAcetamide, N-[2-(4-morpholinyl)phenyl]-2-[[5,6,7,8-tetrahydro-2-(2-phenylethyl)[1]benzothieno[2,3-d]pyrimidin-4-yl]thio]-;ASN05260065;iHCK-37;iHCK-37 (ASN05260065)
CAS No.516478-09-4

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACEHQQ743 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACXUBE428 route compound structure diagram
    ACXUBE4285585-33-1 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACEHQQ743 route product structure diagram
    ACEHQQ743516478-09-4
Inquiry

2. ACEHQQ743 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACEHQQ743 route product structure diagram
    ACEHQQ743516478-09-4
Inquiry

Comments (0)